Insider · CIK 0002022156
Krishnaswamy Yeleswaram
Files at RAPP (Rapport Therapeutics, Inc.). First filing Jan 5, 2026, latest Mar 26, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RAPP: Rapport Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 17Weak | Rapport Therapeutics, Inc. | $303k 10,115 shares | -3% | +249% from low-9% from high | |
| 39Weak | Rapport Therapeutics, Inc. | $85k 2,840 shares | -1% | +324% from low-5% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 25, 2026 | RAPP Rapport Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -10,115 | $29.99 | $303k | 286,876 | Mar 26, 2026 |
| Feb 2, 2026 | RAPP Rapport Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +120,000 | $0.00 | $0 | 120,000 | Feb 4, 2026 |
| Dec 31, 2025 | RAPP Rapport Therapeutics, Inc. | AGrant or award Common Stock | +9,000 | - | - | 299,831 | Jan 5, 2026 |
| Dec 31, 2025 | RAPP Rapport Therapeutics, Inc. | SOpen-market sale Common Stock | -2,840 | $30.05 | $85k | 296,991 | Jan 5, 2026 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.